Stock EVOK EVOKE PHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Evoke Pharma, Inc.

Equities

EVOK

US30049G2030

Real-time Estimate Cboe BZX
Other stock markets
 12:27:56 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.472 USD +8.26% Intraday chart for Evoke Pharma, Inc. +1.39% -54.77%
Apr. 24 Transcript : Evoke Pharma, Inc. - Special Call
Mar. 21 Evoke Pharma, Inc. Announces Board Changes as of March 31, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Evoke Pharma, Inc. - Special Call
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
AQ
Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer
AQ
Evoke Pharma, Inc. Announces Board Changes as of March 31, 2024
CI
Evoke Pharma, Inc. Announces Chief Executive Officer Changes as of March 31, 2024
CI
Transcript : Evoke Pharma, Inc., Q4 2023 Earnings Call, Mar 14, 2024
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
AQ
Evoke Pharma, Inc. Provides Earnings Guidance for 2024
CI
Evoke Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
AQ
Evoke Pharma Announces Closing of $7.5 Million Public Offering
AQ
Evoke Pharma Prices Underwritten Public Offering
MT
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
AQ
Revolutionizing gastroparesis treatment: Evoke Pharma's CEO talks game-changing nasal spray
AQ
Evoke Pharma Says FDA Lists Latest US Patent for Gimoti in Orange Book
MT
Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent
AQ
Evoke Pharma : Failure to Satisfy Listing Rule - Form 8-K
PU
Evoke Pharma - United States Patent and Trademark Office Grants another Formulation Patent Covering GIMOTI
AQ
United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI
AQ
Evoke Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EVOK Stock
  4. News Evoke Pharma, Inc.